02. Renal Tubular Acidosis

Definition

Impaired acid-base metabolism by the kidney in the setting of normal glomerular filtration, specifically of either renal bicarbonate reabsorption or hydrogen ion excretion.

  • Kidney disease must be excluded as etiology of inappropriate acid-base metabolism.
  • Characterized by a normal-anion gap metabolic acidosis with hyperchloremia.

** Note: normal urine pH range is 4.5-5.0 as virtually no HCO3 is excreted.

Categories

  • Type I RTA (distal):
  • Urinary acidification takes place in the distal nephron in the intercalated cells by regeneration of HCO3 (10-20%) and secretion of H+ in the form of H2PO4- and NH4+. In type I RTA, there is impaired secretion of H+ leading to metabolic acidosis.
    • Primary.
    • Amphotericin.
    • Sjogren’s/SLE/RA.
    • Myeloma.
    • Marked volume depletion.
    • Urinary tract obstruction (stones).
    • Potassium sparing diuretics (amiloride).
  • Features/Diagnosis:
    • Serum HCO3 may be <10mEq/L as there is no way to excrete the acid load.
    • Urine pH >5.5 reflecting defect in urinary acidification and sufficient NH3 production to buffer few H+ secreted.
  • Type II RTA (proximal):
  • Reclamation of 80-90% of HCO3 occurs in the proximal tubule. In type II RTA, HCO3 wasting occurs due to failed reabsorption that can be only partially salvaged by the distal nephron.
  • Primary.
  • Myeloma nephropathy (most common cause in adults).
  • Acetazolamide.
  • Heavy metals (Pb, Cd, Hg, Cu, others).
  • Inherited and acquired Fanconi syndrome.
  • Fanconi syndrome refers to generalized proximal tubular dysfunction and can be primary or secondary to many of the above causes of type II RTA. 
  • Features/Diagnosis:
  • As the serum HCO3 level drops, eventually the lower filtered load of HCO3 into the proximal tubule will be able to be maximally re-absorbed. Serum HCO3 levels will be maintained between 12-20mEq/L, a kind of steady-state.
  • Urine pH is variable.
  • Giving HCO3 load for acidosis (test dose) raises serum HCO3 levels and overwhelms the proximal tubule absorptive capacity leading to HCO3 excess which raises urine pH >5.5.
  • If serum HCO3 is low enough such that all of the filtered HCO3 can be re-absorbed, then the normally functioning distal nephron can acidify, leading to a urine pH <5.3.
  • Type IV RTA (distal) - most common type of RTA:
  • Aldosterone deficiency or resistance in the intercalated and principle cells of the distal nephron lead to hyperkalemia and impaired NH3/NH4+ production and thus metabolic acidosis.
  • Hypoaldosteronism-medicated causes:
  • Diabetic nephropathy (most common cause).
  • Chronic interstitial nephropathy.
  • Drugs (NSAIDS, heparin, ACEI/ARB, trimethoprim, calcineurin inhibitors).
  • Addison's disease.
  • Aldosterone-resistance mediated causes:
  • Sickle cell anemia (most common cause of aldosterone resistance).
  • BPH.
  • Features/Diagnosis:
  • Serum HCO3 usually >15mEq/L.
  • Urine pH <5.3: in contrast to type I RTA, there is insufficient NH3 production in type IV RTA, leaving few H+ produced to be left unbuffered and thus cause a low urinary pH.

Evaluation

  • Laboratory:
  • Urine: UA/urine culture (UTI from urea-producing organisms can raise urine pH by metabolism of HCO3 and NH4+), urine lytes (Na, K, Cl).
    • Calculate urine anion gap: 
      • UAG = UNa + UK - UCl.
      • If UAG <0, not likely RTA. Consider GI causes.
      • Note: UAG cannot be used in setting of presence of other anion (e.g. lactate, DKA) OR with urine sodium <20mEq/L (insufficient Na+ delivery to distal tubule does not allow for H+ exchange and, thus, urinary acidification).
      • If urine sodium <20mEq/L, consider calculating urine osmolar gap (needs urine Na, Cl, K, BUN, glucose, osmolality).
      • UOG = 2(UNa + UK) + U[BUN]/2.8 + Uglucose/18.
      • UOG <50 is suggestive of RTA.
  • Serum: ABG, serum chemistry.
    • Hypokalemia: type II RTA (proximal) or type I RTA (distal).
  • If type II: in adults, suspect multiple myeloma or nucleotide analogues; in pediatric patients, Fanconi’s syndrome.
  • If type I: in adults, suspect urinary obstruction or Sjogren’s/SLE.
  • Hyperkalemia: type IV RTA (hypoaldosteronism) or type I RTA (distal).
  • If type IV: suspect diabetic nephropathy or sickle cell anemia.
  • If type I: suspect impaired Na reabsorption:
  • Urinary obstruction.
  • Cyclosporine toxicity.
  • Autoimmune disorders.
  • TMP/SMX can impair Na channels leading to a functional type I RTA.

Treatment

  • Type I and II: aggressive K supplementation. Follow with HCO3 supplementation (initial HCO3 supplementation can aggravate K wasting especially in proximal RTA).
  • NaHCO3 or Na-citrate: goal normal serum HCO3 in type I. HCO3 >20mEq/L in Type II
  • Note: may need close monitoring/repletion of K+, Ca2+, phosphate.
  • Type IV: treatment for hyperkalemia.
  • Restrict dietary potassium, avoid potassium-sparing diuretics.
  • Loop diuretics, thiazides for potassium excretion.
  • Fludricortisone in severe cases.

Key Points

  • RTA is best diagnosed in the presence of normal GFR (with significant CKD or AKI, most kidney has decreased ammoniagenesis).
 

Type I

Type II

Type IV

Location

Distal

Proximal

Distal

Defect

Impaired distal H+ secretion or ability to lower urine pH

Diminished HCO3 resorption

Aldosterone deficiency/ resistance

Urine pH

>5.3

Variable

Usually <5.3

Plasma K+

Low or normal

Low or normal

High

Plasma HCO3

Very low (may be <10mEq/L)

Moderately low (12-20mEq/L)

Usually >15mEq/L

Clinical features

Nephrolithiasis

Small stature, osteodystrophy

Variable; most commonly DM2, SCA

 

Gluck SL.  Electrolyte Quintet: Acid-Base.  Lancet 1998;352:474-479.

Laing CM, Unwin RJ. Renal tubular acidosis. J Nephrol 2006;19 Suppl 9:S46-52.

Reilly, Robert, Nephrology in 30 days. 2005.

Smulders YM, Frissen PH, Slaats EH, Silberbusch J. Renal tubular acidosis. Pathophysiology and diagnosis. Arch Intern Med 1996;156:1629-1636.

Soriano JR. Renal Tubular Acidosis: The Clinical Entity. J Am Soc Nephrol 13: 2160–2170, 2002.

Sterns RH.  Fluid, electrolyte, and acid-base disturbances.  J Am Soc Nephrol 2003;2:1-7.